Acamprosate Calcium Structural Formula (5bf6f9a0 C65b 4301 B599 653fac1b60c2 01)
Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 0378-6333
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 0378-6333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Acamprosate Calcium Delayed-release Tablets 333 mg Bottle Label (Image 01)
Each enteric-coated tablet contains 333 mg of acamprosate's calcium equivalent to 300 mg of acamprosate. The usual dosages are accompanied by prescribing information. The medicine should be kept out of reach of children and stored at 20-25°C. The tablets come in a container with 180 tablets. Manufactured by Tylan Pharmaceuticals for AC. The remaining text consists of codes and lot numbers and does not contain any useful information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
